Abstract
The distribution and retention of intravenously injected hexavalent uranium-233 in the skeleton of the female rat has been investigated using a variety of autoradiographic and radiochemical techniques. These showed that approximately one third of the injected uranium is deposited in the skeleton where it is retained with an initial biological half-time of ∼40 days. The studies also showed that:
1 Uranium is initially deposited onto all types of bone surface, but preferentially onto those that are accreting.
2 Uranium is deposited in the calcifying zones of skeletal cartilage.
3 Bone accretion results in the burial of surface deposits of uranium.
5 Resorbed uranium is not retained by osteoclasts and macrophages in the bone marrow.
6 Uranium removed from bone surfaces enters the bloodstream where most is either redeposited in bone or excreted via the kidneys.
7 The recycling of resorbed uranium within the skeleton tends to produce a uniform level of uranium contamination throughout mineralized bone. These results are taken to indicate that uranium deposition in bone shares characteristics in common with both the 'volume-seeking radionuclides' typified by the alkaline earth elements and with the 'bone surface-seeking radionuclides' typified by plutonium.
Get full access to this article
View all access options for this article.
